Breaking News Instant updates and real-time market news.

WMT

Walmart

$84.39

-1.68 (-1.95%)

, CSCO

Cisco

$43.46

-1.7 (-3.76%)

16:17
05/17/18
05/17
16:17
05/17/18
16:17

On The Fly: Top stock stories for Thursday

Stocks began the session little changed and moved in a fairly narrow range throughout the day. The averages pared their opening losses and moved higher into the lunch hour as investors watched for reports on U.S. trade talks with China, which have been ongoing but have not yet resulted in a deal. The sellers gained control following comments from President Trump that he was not optimistic a deal with China could be reached and questioned whether North Korea was still committed to a planned meeting in June. The averages moved to session lows, then recovered slightly and drifted into the close. ECONOMIC EVENTS: In the U.S., initial jobless claims rose 11,000 to 222,000 in the week ended May 12. The Philadelphia Fed Business Outlook Survey climbed 11.2 points to a 34.4 reading, which was much stronger than expected. An index of leading economic indicators rose another 0.4% to 109.4 in April, as expected. COMPANY NEWS: Shares of Walmart (WMT) fell 2% despite the company reporting better than expected results for the first quarter, with U.S. comp sales increasing 2.1% year-over-year in the period. The retail giant reiterated, however, that its investment in Flipkart is expected to negatively impact fiscal 2019 earnings per share by roughly 25c-30c if the deal closes at the end of the second quarter... Shares of Cisco (CSCO) fell 4% after the company reported quarterly results and provided guidance for the fourth quarter... J.C. Penney (JCP) shares dropped 12% after the retailer reported results for its fiscal Q1 but lowered its adjusted earnings guidance for fiscal 2018... Meanwhile, a judge in the Delaware Chancery Court rejected CBS' (CBS) motion for a restraining order to stop Shari Redstone from interfering with its board meeting where it will consider a proposal to dilute the voting power of National Amusements, the company through which Redstone controls both CBS and Viacom (VIAB). In response, CBS said that the Court "clearly recognizes that we may bring further legal action to challenge any actions by NAI that we consider to be unlawful, and we will bring such action if needed to protect the interests of all shareholders." MAJOR MOVERS: Among the noteworthy gainers was Loxo Oncology (LOXO), which jumped 20% after it released data regarding its experimental LOXO-292 cancer drug. Also higher was PayPal (PYPL), which rose about 2% after media reports said that the payments company is near a deal to buy European fintech startup iZettle for roughly $2.2B. Among the notable losers was Jounce Therapeutics (JNCE), which plunged 35% after the company's report of "underwhelming" JTX2011 data ahead of the ASCO meeting led to a downgrade of the stock at Wells Fargo. Also lower was Flowers Foods (FLO), which fell 9.5% after reporting quarterly results. INDEXES: The Dow fell 54.95, or 0.22%, to 24,713.98, the Nasdaq lost 15.82, or 0.21%, to 7,382.47, and the S&P 500 declined 2.33, or 0.09%, to 2,720.13.

WMT

Walmart

$84.39

-1.68 (-1.95%)

CSCO

Cisco

$43.46

-1.7 (-3.76%)

JCP

J.C. Penney

$2.69

-0.39 (-12.66%)

CBS

CBS

$51.61

-2.205 (-4.10%)

VIA

Viacom

$34.55

0.6 (1.77%)

VIAB

Viacom

$28.16

-0.1 (-0.35%)

PYPL

PayPal

$79.21

1.39 (1.79%)

LOXO

Loxo Oncology

$167.78

28.825 (20.74%)

JNCE

Jounce Therapeutics

$11.40

-6.26 (-35.45%)

FLO

Flowers Foods

$19.54

-2.08 (-9.62%)

  • 17

    May

  • 17

    May

  • 17

    May

  • 18

    May

  • 22

    May

  • 23

    May

  • 30

    May

  • 30

    May

  • 01

    Jun

  • 01

    Jun

  • 07

    Jun

  • 12

    Jun

  • 10

    Jul

WMT Walmart
$84.39

-1.68 (-1.95%)

05/17/18
JEFF
05/17/18
NO CHANGE
Target $106
JEFF
Buy
Walmart e-commerce acceleration important after Q4 disappointed, says Jefferies
Jefferies analyst Daniel Binder noted that Walmart reported U.S. ecommerce growth accelerated sequentially in Q1 to 33% from 24%, which was important for investors disappointed in Q4. The company's gross margin percentage decline was also better than feared, noted Binder, who maintains a Buy rating on Walmart shares but trimmed his price target on the stock to $106 from $119.
05/17/18
GDHS
05/17/18
DOWNGRADE
GDHS
Accumulate
Walmart downgraded to Accumulate from Buy at Gordon Haskett
05/17/18
BARD
05/17/18
NO CHANGE
Target $95
BARD
Outperform
Walmart Q1 results all in all very positive, says Baird
Baird analyst Peter Benedict noted Walmart reported Q1 results which beat both his and Street estimates. The analyst said results were driven by higher sales and better gross margins, but noted comps were a touch light, citing seasonal trends in April. He said the results were positive overall with better sales, gross margins, and e-commerce acceleration outweighing the slight U.S. comp deceleration. Benedict reiterated his Outperform rating and $95 price target on Walmart shares.
05/16/18
MKMP
05/16/18
NO CHANGE
Target $93
MKMP
Buy
Target to benefit from strong digital sales, says MKM Partners
MKM Partners analyst Patrick McKeever kept his Buy rating and $93 price target on Target Corp (TGT) ahead of its Q1 earnings next week. The analyst says the aggressive Street consensus for earnings is "doable" in spite of the negative impact from cold weather in the East, noting that the quarter will likely see more strong growth in digital sales driven by more "expedient" fulfillment and new orders. McKeever adds that despite the 12% run in the stock price year-to-date, its valuation is still 3.4 points below that of Walmart (WMT) on "overly pessimistic" investor sentiment. The analyst says Target remains his "Top Pick" in the space in 2018.
CSCO Cisco
$43.46

-1.7 (-3.76%)

05/17/18
MSCO
05/17/18
NO CHANGE
Target $50
MSCO
Overweight
Cisco laying groundwork for upside in FY19, says Morgan Stanley
Following Cisco's report of "strong" Q3 results and "generally positive" comments from management regarding the outlook, Morgan Stanley analyst James Faucette said the earnings call "offered ample evidence" Cisco's software strategy is progressing well. He sees software helping to stabilize equipment replacement cycles and believes the stock will approach $50 as the market becomes more convinced FY19 estimates are too low. Faucette maintains an Overweight rating and $50 price target on Cisco shares.
05/17/18
JMPS
05/17/18
NO CHANGE
JMPS
Market Perform
Cisco results bode well for Arista, Nutanix and Palo Alto, says JMP Securities
JMP Securities analyst Erik Suppiger said Cisco (CSCO) noted strength in data center and campus switching in its Q3 earnings report, which suggests to him that demand trends are favorable for Arista Networks (ANET). In the DC business, Cisco noted it grew double digits year-over-year driven by its hyperconverged infrastructure product, which Suppiger sees pointing to favorable demand for Nutanix (NTNX). Additionally, security sales re-accelerated in the quarter to double-digit growth for the first time in over a year, which the analyst reads as a favorable trend for Palo Alto Networks (PANW). On Cisco itself, Suppiger said he sees the stock as fairly valued and he maintains a Market Perform rating on the shares.
05/17/18
BARD
05/17/18
NO CHANGE
Target $51
BARD
Outperform
Cisco weakness a buying opportunity, says Baird
Baird analyst Jayson Noland said Cisco posted a solid quarter on nearly all metrics and recommended buying the dip in the shares. The analyst said the selloff was due in part to high expectations against its in-line Q4 guidance. Noland reiterated his Outperform rating and $51 price target on Cisco shares.
05/17/18
RBCM
05/17/18
NO CHANGE
Target $50
RBCM
Outperform
Cisco post-earnings stock dip is a buying opportunity, says RBC Capital
RBC Capital analyst Mitch Steves kept his Outperform rating and $50 price target on Cisco, saying the slight pullback in the stock price following the in-line earnings and guidance may be a buying opportunity. The analyst cites continued growth in deferred revenues while also forecasting growth in Switching sales for 2-3 quarters given the backlog and its high margin levels. Steves also notes Cisco's history of buybacks when its stock price traded in $42-$44 per share range, creating a "nice support for the stock".
JCP J.C. Penney
$2.69

-0.39 (-12.66%)

11/30/17
COWN
11/30/17
NO CHANGE
Target $4
COWN
Market Perform
J.C. Penney taking steps toward a comeback, says Cowen
Cowen analyst Oliver Chen met with J.C. Penney and said he is confident the company's liquidity, its multi-year ability to drive free cash flow, and controlled capital expenditures will mitigate some risk. He likes management's simplification of marketing, its value messaging and execution, and leveraging of non-apparel categories, which should drive greater consistency in traffic and growth. Chen maintains his Market Perform rating and $4 price target on J.C. Penney shares as he looks for visibility on greater consistency in traffic trends.
04/19/18
MSCO
04/19/18
NO CHANGE
Target $1550
MSCO
Overweight
Amazon gaining apparel market share in U.S., says Morgan Stanley
Morgan Stanley analyst Brian Nowak said his analysis shows that Amazon (AMZN) gained 1.5% of U.S. apparel market share in 2017, largely at the expense of department stores. He estimates Amazon is the second largest U.S. apparel retailer, trailing only Walmart (WMT), and expects the e-commerce giant to take the number one spot in terms of U.S. apparel market share in 2018. Cumulatively, Nowak estimates Sears (SHLD), Macy's (M) and J.C. Penney (JCP) lost 0.8% share in 2017, with shareholdings remaining roughly flat for Target (TGT) and Kohl's (KSS). He maintains an Overweight rating and $1,550 price target on Amazon shares.
03/12/18
FBCO
03/12/18
INITIATION
Target $2.5
FBCO
Underperform
J.C. Penney initiated with an Underperform at Credit Suisse
Credit Suisse initiated J.C. Penney with an Underperform and $2.50 price target.
12/22/17
MSCO
12/22/17
NO CHANGE
MSCO
TJX stands to benefit from Bon-Ton closures, says Morgan Stanley
After analyzing which department stores and off-price retailers have the greatest overlap with troubled retailer Bon-Ton Stores (BONT), Morgan Stanley analyst Kimberly Greenberger found that over 40% of Bon-Ton's have a TJX (TJX) concept within a one mile radius and she sees it as the retailer that could benefit the most from a Bon-Ton liquidity event. Though Sears (SHLD) has the greatest overlap overall, there is no evidence to suggest it, nor Kohl's (KSS) and J.C. Penney (JCP), have been able to capitalize on Bon-Ton's struggles so far, added Greenberger.
CBS CBS
$51.61

-2.205 (-4.10%)

05/17/18
05/17/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Molson Coors (TAP) downgraded to Hold from Buy at Stifel with analyst Mark Swartzberg saying he sees multiple expansion as unlikely because U.S. beer industry volume trends are getting worse, the company's U.S. share trends are not improving, and demographics favor continued pressure on per capita alcohol consumption. 2. Progressive (PGR) downgraded to Market Perform from Outperform at Keefe Bruyette with analyst Meyer Shields citing valuation. 3. CBS (CBS) downgraded to Neutral from Buy at BofA/Merrill with analyst Jessica Reif saying the lawsuit brought by CBS and the special committee alleging a breach of fiduciary duty by the National Amusements Inc. is a significant overhang for shares and will constrain outperformance until a ruling. 4. Canadian National (CNI) downgraded to Neutral on valuation at Macquarie with analyst Konark Gupta citing valuation. 5. Jounce Therapeutics (JNCE) downgraded to Market Perform from Outperform at Wells Fargo with analyst Jim Birchenough saying overall response rates for JTX-2011 monotherapy in gastric cancer and in triple negative breast cancer, as well as for JTX-2011 plus Opdivo in gastric cancer and in triple negative breast cancer are "underwhelming" and "not competitive with other investigational drugs." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/17/18
WELS
05/17/18
NO CHANGE
WELS
Market Perform
CBS shares likely return to mid-$60's with no merger, says Wells Fargo
Wells Fargo analyst Marci Ryvicker sees three potential paths unfolding for CBS (CBS) and Viacom (VIAB). The first being CBS remaining a standalone company with Les Moonves in charge. In this scenario the analyst sees CBS shares re-rating to $64, but ultimately being worth $78, and Viacom retreating to $26.50, but being worth $35-$39. The second scenario has CBS and Viacom merging with Moonves in charge. Under this, the new CBS is worth $55 per share with Viacom taken out at $32, Ryvicker tells investors in a research note. Her third scenario has CBS and Viacom merging with Bob Bakish in charge. The analyst values the new CBS at $44 per share in this scenario. At this point, Ryvicker favors a go-it-alone strategy for CBS. She also likes what Bakish is doing at Viacom. The analyst keeps Market Perform rating on both stocks, however, citing the lack of visibility on the outcome or timing.
05/17/18
05/17/18
DOWNGRADE
Target $58

Neutral
CBS downgraded to Neutral on lawsuit overhang at BofA/Merrill
As previously reported, BofA/Merrill downgraded CBS to Neutral from Buy and cut its price target to $58 from $78. Analyst Jessica Reif said the lawsuit brought by CBS and the special committee alleging a breach of fiduciary duty by the National Amusements Inc. is a significant overhang for shares and will constrain outperformance until a ruling. Further, Reif sees increased risk that CEO Leslie Moonves could leave the company, which would elevate execution risk.
05/17/18
BOFA
05/17/18
DOWNGRADE
BOFA
Neutral
CBS downgraded to Neutral from Buy at BofA/Merrill
VIA Viacom
$34.55

0.6 (1.77%)

03/28/18
SBSH
03/28/18
UPGRADE
Target $30
SBSH
Neutral
Viacom upgraded to Neutral from Sell at Citi
Citi analyst Jason Bazinet upgraded Viacom (VIAB) to Neutral and raised his price target for the shares to $30 from $26. The analyst assigns a 50% probability of a merger with CBS (CBS) and believes Viacom shares would be worth $30 under such a scenario.
05/15/18
SBSH
05/15/18
NO CHANGE
Target $66
SBSH
Buy
Citi drops likelihood of CBS-Viacom merger to 25% from 50%
Citi analyst Jason Bazinet dropped his likelihood of a CBS (CBS), Viacom (VIAB) merger to 25% from 50% after CBS filed a Delaware lawsuit asking for a restraining order to prevent Shari Redstone from interfering with a special CBS board meeting. The analyst now sees a lower chance of CBS acquiring Viacom. As such, he increased his price target for CBS shares to $66 from $61 and lowered his price target for Viacom shares to $29 from $30.
05/07/18
SPHN
05/07/18
NO CHANGE
Target $58
SPHN
Equal Weight
CBS-Viacom deal could work at Class B shareholders' expense, says Stephens
Stifel analyst Kyle Evans contends that CBS (CBS) posted the kind of quarter that should fundamentally separate the company from many media peers. However, he said there is no more clarity following its report on whether its Class A shareholders will push for a combination with Viacom (VIAB) that "undermines Class B holders." Evans lowered his price target on CBS to $58 from $64 and maintains an Equal Weight rating on the stock.
04/30/18
BARD
04/30/18
NO CHANGE
Target $33
BARD
Neutral
Twitter's new partnerships highlight 'growing relevance,' says Baird
Disney's (DIS) and Viacom's (VIAB) announced live content/streaming partnerships with Twitter (TWTR) highlight Twitter's "growing relevance as a distribution platform," Baird analyst Colin Sebastian tells investors in a research note. He believes the partnerships should provide tailwinds for Twitter's video advertising business. Video accounts for greater than 50% of Twitter ad revenue and is its fastest growing ad format, Sebastian points out. The analyst says Disney and Viacom represent two of the company's biggest partnership wins to-date. He keeps a Neutral rating on Twitter with a $30 price target. The stock closed the trading day up 4.5% to $30.31.
VIAB Viacom
$28.16

-0.1 (-0.35%)

PYPL PayPal
$79.21

1.39 (1.79%)

05/17/18
NOMU
05/17/18
NO CHANGE
Target $100
NOMU
Buy
PayPal investor day to serve as positive catalyst, says Nomura Instinet
Nomura Instinet analyst Bill Carcache expects PayPal's upcoming investor day to serve as a positive catalyst for the shares. The stock has range bound most of this year, as the benefit of positive earnings revisions has been largely offset by multiple compression that started when the company announced its eBay (EBAY) breakup at the end of January, Carcache tells investors in a research note. He raised his price target for PayPal shares to $100 from $98 and thinks the investor day will reignite investor enthusiasm. Carcache keeps a Buy rating on the name.
05/16/18
NOMU
05/16/18
NO CHANGE
Target $65
NOMU
Buy
Square app downloads growing faster than PayPal, says Nomura Instinet
Nomura Instinet analyst Dan Dolev says his firm's monthly app tracker shows Square (SQ) Cash App downloads are growing faster than PayPal's (PYPL) Venmo, with growth accelerating in recent months. In bitcoin, while Coinbase downloads are slowing versus peak, Square "remains balanced," Dolev tells investors in a research note titled "Tracker Shows SQ Cash App Is Surging." The analyst reiterates a Buy rating on Square with a $65 price target.
05/03/18
BERN
05/03/18
NO CHANGE
BERN
Amazon poses a long-term risk to PayPal, says Bernstein
Bernstein analyst Harshita Rawat notes that Bloomberg reported that Amazon (AMZN) is offering discounts to merchants to adopt Amazon Pay. While the analyst sees limited "new news," he believes that Amazon poses a long-term, risk to PayPal (PYPL). Regarding impact on Visa (V) and MasterCard (MA), Rawat does believe Amazon brings some risk of brand obfuscation, pricing pressure and yet another formidable payment wallet to contend with. However, the risk is more contained than is often perceived, he adds.
05/03/18
WELS
05/03/18
NO CHANGE
WELS
Fears over 'Amazon Pay' may be overdone, says Wells Fargo
Wells Fargo analyst Timothy Willi notes that media reports mentioned that Amazon (AMZN) is approaching small businesses about offering its "Amazon Pay" platform to accept payments and benefit from the lower transactions costs that Amazon can provide as a result of its scale. While the analyst believes this could potentially be a threat to names like PayPal (PYPL) and others, fears may be overdone and the impact of this strategy may not be as severe as expected. Specifically, Willi argues that merchants view Amazon as a competitor, PayPal has very competitive economics given the size of its volume and global basis, and many Amazon Pay shoppers are likely to be PayPal account holders and inertia may limit their inclination to switch to Amazon Pay at merchants where they are currently using PayPal.
LOXO Loxo Oncology
$167.78

28.825 (20.74%)

05/17/18
STFL
05/17/18
NO CHANGE
Target $190
STFL
Buy
Loxo Oncology price target raised to $190 after ASCO abstracts at Stifel
Stifel analyst Stephen Willey said he believes the preliminary efficacy data on Loxo Oncology's (LOXO) LOXO-292 that was reported in abstracts released last night in anticipation of the ASCO meeting should further distance the candidate from other competitive RET inhibitors. The overall response rate, or ORR, of 52% reported for the 46 evaluable patients harboring RET-altered tumors tops the 46% ORR previously-reported for competitor Blueprint Medicines' (BPMC) BLU-667 at AACR, noted Willey. The analyst, who also thinks the disclosure of this data increases visibility for potential strategic buyers who have historically shown a "willingness to pay top-dollar for long-duration targeted oncology agents," increased his price target on Loxo to $190 from $145 and keeps a Buy rating on the shares.
05/09/18
JMPS
05/09/18
NO CHANGE
Target $152
JMPS
Outperform
Loxo Oncology price target increased to $152 from $95 at JMP Securities
JMP Securities analyst Konstantinos Aprilakis raised his price target on Loxo Oncology to $152 from $95 following an update to his financial model after the company's Q1 earnings report, which he said highlighted its pipeline progress. He maintains an Outperform rating on Loxo shares.
04/16/18
STFL
04/16/18
NO CHANGE
STFL
Buy
Blueprint data leaves 'door wide open' for Loxo's LOXO-292, says Stifel
Stifel analyst Stephen Willey noted that Blueprint Medicines (BPMC) reported data from the dose-escalation portion of its Phase 1 trial of BLU-667 at this weekend's AACR meeting. He believes BLU-667 looks like "a sufficiently viable asset for RET-altered tumors," but he also thinks the data has left the competitive window "wide-open" for Loxo Oncology (LOXO) ahead of preliminary LOXO-292 data expected at the ASCO meeting in June. Loxo's data now potentially could shift sentiment on what consensus has been presuming to be a $1B+ opportunity equally-shared between the two companies, Willey tells investors. He maintains a Buy rating on Loxo shares.
05/17/18
JMPS
05/17/18
NO CHANGE
Target $182
JMPS
Outperform
Loxo Oncology price target raised to $182 from $152 at JMP Securities
JMP Securities analyst Konstantinos Aprilakis raised his price target on Loxo Oncology (LOXO) shares to $182 from $152 after the release of ASCO abstracts featuring "impressive data" for LOXO-292 in patients with RET-fusion cancers. The overall response rate in 46 evaluable patients across all RET alterations and tumor types was 52%, noted Aprilakis, who points out that Blueprint Medicines (BPMC) presented data from the Phase I ARROW trial of BLU-667 in 53 patients with RET-altered solid tumors at the AACR annual meeting in April and the ORR it reported across all patients was 45%. The analyst keeps an Outperform rating on Loxo shares.
JNCE Jounce Therapeutics
$11.40

-6.26 (-35.45%)

05/17/18
HCWC
05/17/18
NO CHANGE
Target $19
HCWC
Buy
Jounce Therapeutics price target lowered to $19 from $33 at H.C. Wainwright
H.C. Wainwright analyst Debjit Chattopadhyay lowered his price target for Jounce Therapeutics to $19 citing the "limited activity on show" for JTX-2011, either as a monotherapy or when used in combination with Opdivo. With the stock already down today, "a reactionary downgrade here would make little sense," Chattopadhyay tells investors in a research note. He keeps a Buy rating on the shares.
05/17/18
WELS
05/17/18
DOWNGRADE
Target $13
WELS
Market Perform
Wells Fargo downgrades Jounce on 'underwhelming' JTX2011 data
Wells Fargo analyst Jim Birchenough downgraded Jounce Therapeutics to Market Perform from Outperform and cut his price target for the shares to $13 from $37. The stock in premarket trading is down 31%, or $5.43, to $12.24. Overall response rates for JTX-2011 monotherapy in gastric cancer and in triple negative breast cancer, as well as for JTX-2011 plus Opdivo in gastric cancer and in triple negative breast cancer are "underwhelming" and "not competitive with other investigational drugs," Birchenough tells investors in a research note following review of the ASCO abstract. He advises taking a "wait and see approach to assess strength of aggregate data."
05/17/18
WELS
05/17/18
DOWNGRADE
WELS
Market Perform
Jounce Therapeutics downgraded to Market Perform from Outperform at Wells Fargo
FLO Flowers Foods
$19.54

-2.08 (-9.62%)

04/03/18
HDLY
04/03/18
INITIATION
Target $25
HDLY
Long-Term Buy
Flowers Foods initiated with a Long-Term Buy at Hilliard Lyons
Hilliard Lyons analyst Jeffrey Thomison started Flowers Foods with a Long-term Buy rating, saying he considers it a well-run, high-quality operator that he thinks will see earnings growth return in 2018. He set a two-year price target of $25 on the stock.
03/27/18
KEYB
03/27/18
INITIATION
Target $24
KEYB
Overweight
Flowers Foods initiated with an Overweight at KeyBanc
KeyBanc analyst David Carlson started Flowers Foods with an Overweight rating and $24 price target. The analyst sees good visibility for fiscal 2018 and believes the share reflect low expectations on the company's long-term plan.
04/17/18
04/17/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. GrubHub (GRUB) initiated with an Overweight at Stephens. 2. Dropbox (DBX) initiated with an Outperform at Macquarie and JMP Securities, an Overweight at KeyBanc, JPMorgan, and Piper Jaffray, a Buy at Canaccord and Deutsche Bank, a Sector Perform at RBC Capital, a Neutral at BofA/Merrill and Goldman Sachs, as well as a Hold at Jefferies. 3. Oneok (OKE) initiated with a Neutral at Seaport Global. 4. Jeld-Wen (JELD) initiated with a Hold at Jefferies. 5. Flowers Foods (FLO) resumed with a Hold at Deutsche Bank. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/17/18
DBAB
04/17/18
INITIATION
Target $24
DBAB
Hold
Flowers Foods resumed with a Hold at Deutsche Bank
Deutsche Bank analyst Rob Dickerson resumed coverage of Flowers Foods with a Hold rating and $24 price target. The analyst believes much of the near-term upside is already priced into the stock.

TODAY'S FREE FLY STORIES

KORS

Michael Kors

$68.63

0.25 (0.37%)

, LULU

Lululemon

$106.18

-0.19 (-0.18%)

11:07
05/26/18
05/26
11:07
05/26/18
11:07
Periodicals
Dollar Tree looks interesting, Barron's says »

Next week, another 20…

KORS

Michael Kors

$68.63

0.25 (0.37%)

LULU

Lululemon

$106.18

-0.19 (-0.18%)

GME

GameStop

$12.64

-0.1 (-0.78%)

DLTR

Dollar Tree

$95.23

0.59 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 31

    May

  • 31

    May

  • 12

    Jun

  • 14

    Jun

  • 26

    Jun

KHC

Kraft Heinz

$57.78

0.72 (1.26%)

, QCOM

Qualcomm

$59.95

0.85 (1.44%)

10:58
05/26/18
05/26
10:58
05/26/18
10:58
Periodicals
Kraft Heinz, J&J among safe, 'solid' dividend stocks, Barron's says »

Kraft Heinz (KHC),…

KHC

Kraft Heinz

$57.78

0.72 (1.26%)

QCOM

Qualcomm

$59.95

0.85 (1.44%)

MRK

Merck

$59.08

-0.03 (-0.05%)

TGT

Target

$71.22

0.28 (0.39%)

OMC

Omnicom

$71.98

-0.1 (-0.14%)

CCL

Carnival

$64.27

0.12 (0.19%)

JNJ

Johnson & Johnson

$121.40

0.06 (0.05%)

MMM

3M

$198.98

-0.38 (-0.19%)

LLY

Eli Lilly

$82.75

0.05 (0.06%)

VLO

Valero

$118.81

-3.06 (-2.51%)

EMR

Emerson

$72.50

-0.77 (-1.05%)

WBA

Walgreens Boots Alliance

$63.52

0.09 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 30

    May

  • 30

    May

  • 02

    Jun

  • 04

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 07

    Jun

  • 12

    Jun

  • 19

    Jun

  • 10

    Sep

  • 23

    Oct

MU

Micron

$61.33

-0.15 (-0.24%)

10:48
05/26/18
05/26
10:48
05/26/18
10:48
Periodicals
Micron can solve low valuation, Barron's says »

Micron's stock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 20

    Jun

ATUS

Altice USA

$18.50

-0.05 (-0.27%)

10:40
05/26/18
05/26
10:40
05/26/18
10:40
Periodicals
Altice's spinoff could be winning bet, Barron's says »

On June 8, Altice will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 30

    May

MU

Micron

$61.33

-0.15 (-0.24%)

, XLNX

Xilinx

$69.63

0.88 (1.28%)

10:35
05/26/18
05/26
10:35
05/26/18
10:35
Periodicals
AI revolution just getting started, Barron's says »

Artificial Intelligence…

MU

Micron

$61.33

-0.15 (-0.24%)

XLNX

Xilinx

$69.63

0.88 (1.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 20

    Jun

ZTCOY

ZTE Corp.

$0.00

(0.00%)

, DDAIF

Daimler AG

$0.00

(0.00%)

08:08
05/26/18
05/26
08:08
05/26/18
08:08
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

ZTCOY

ZTE Corp.

$0.00

(0.00%)

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$21.82

-0.445 (-2.00%)

HMC

Honda

$32.04

-0.34 (-1.05%)

NSANY

Nissan

$0.00

(0.00%)

F

Ford

$11.51

-0.11 (-0.95%)

GM

General Motors

$38.30

-0.09 (-0.23%)

TM

Toyota

$129.97

-2.47 (-1.87%)

VLKAY

Volkswagen

$0.00

(0.00%)

BAC

Bank of America

$30.16

-0.03 (-0.10%)

C

Citi

$68.42

-0.86 (-1.24%)

GS

Goldman Sachs

$235.05

-1.1 (-0.47%)

JPM

JPMorgan

$110.62

-0.64 (-0.58%)

MS

Morgan Stanley

$53.02

-0.96 (-1.78%)

USB

U.S. Bancorp

$50.54

-0.14 (-0.28%)

WFC

Wells Fargo

$54.91

0.25 (0.46%)

TWTR

Twitter

$33.64

0.11 (0.33%)

AA

Alcoa

$47.92

-1.26 (-2.56%)

CENX

Century Aluminum

$16.27

-0.07 (-0.43%)

AOBC

American Outdoor Brands

$12.53

0.05 (0.40%)

RGR

Sturm, Ruger

$63.10

0.5 (0.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 30

    May

  • 01

    Jun

  • 06

    Jun

  • 20

    Jun

  • 22

    Jun

  • 13

    Jul

  • 27

    Jul

  • 10

    Sep

  • 12

    Oct

  • 14

    Jan

  • 15

    Apr

  • 15

    Jul

  • 15

    Oct

HCLP

Hi-Crush Partners

$13.20

-0.825 (-5.88%)

17:54
05/25/18
05/25
17:54
05/25/18
17:54
Hot Stocks
Hi-Crush Partners provides update on bulldozer incident in Whitehall facility »

Hi-Crush Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

POST

Post Holdings

$77.98

1.49 (1.95%)

17:37
05/25/18
05/25
17:37
05/25/18
17:37
Hot Stocks
Post Holdings reports fire in Michael Foods' plant in Pennsylvania »

Post Holdings reported a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

ABMD

Abiomed

$394.49

0.04 (0.01%)

, WYN

Wyndham

$107.98

-0.58 (-0.53%)

17:34
05/25/18
05/25
17:34
05/25/18
17:34
Hot Stocks
Abiomed to enter S&P 500 index on May 31 »

S&P MidCap 400…

ABMD

Abiomed

$394.49

0.04 (0.01%)

WYN

Wyndham

$107.98

-0.58 (-0.53%)

MSCC

Microsemi

$68.74

0.005 (0.01%)

PRAH

PRA Health

$81.19

0.33 (0.41%)

GME

GameStop

$12.64

-0.1 (-0.78%)

FRED

Fred's

$1.69

0.05 (3.05%)

PRSP

Symbol now PB

$0.00

(0.00%)

RRTS

Roadrunner

$2.19

0.04 (1.86%)

DXC

DXC Technology

$94.20

-5.42 (-5.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 05

    Jun

  • 12

    Jun

PRAH

PRA Health

$81.19

0.33 (0.41%)

, ABMD

Abiomed

$394.49

0.04 (0.01%)

17:24
05/25/18
05/25
17:24
05/25/18
17:24
Hot Stocks
Breaking Hot Stocks news story on PRA Health, Abiomed »

PRA Health to replace…

PRAH

PRA Health

$81.19

0.33 (0.41%)

ABMD

Abiomed

$394.49

0.04 (0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 05

    Jun

  • 12

    Jun

WYN

Wyndham

$107.98

-0.58 (-0.53%)

, MSCC

Microsemi

$68.74

0.005 (0.01%)

17:23
05/25/18
05/25
17:23
05/25/18
17:23
Hot Stocks
Breaking Hot Stocks news story on Wyndham, Microsemi »

Wyndham to replace…

WYN

Wyndham

$107.98

-0.58 (-0.53%)

MSCC

Microsemi

$68.74

0.005 (0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABMD

Abiomed

$394.49

0.04 (0.01%)

, WYN

Wyndham

$107.98

-0.58 (-0.53%)

17:21
05/25/18
05/25
17:21
05/25/18
17:21
Hot Stocks
Breaking Hot Stocks news story on Abiomed, Wyndham »

ABIOMED to replace…

ABMD

Abiomed

$394.49

0.04 (0.01%)

WYN

Wyndham

$107.98

-0.58 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 05

    Jun

  • 12

    Jun

PCG

PG&E

$44.67

0.84 (1.92%)

17:16
05/25/18
05/25
17:16
05/25/18
17:16
Periodicals
CA Forestry Dept rules PG&E equipment responsible for wildfires, Bloomberg says »

Report filed by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FARM

Farmer Bros.

$28.50

0.15 (0.53%)

17:09
05/25/18
05/25
17:09
05/25/18
17:09
Hot Stocks
Levin Capital Strategies reports 8.4% stake in Farmer Bros »

Levin Capital purchased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDLS

Noodles & Company

$8.90

-0.35 (-3.78%)

17:07
05/25/18
05/25
17:07
05/25/18
17:07
Syndicate
Breaking Syndicate news story on Noodles & Company »

Noodles & Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIN

Windstream

$1.22

-0.125 (-9.29%)

17:06
05/25/18
05/25
17:06
05/25/18
17:06
Hot Stocks
Windstream completes one-for-five reverse stock split »

Windstream completed its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDLS

Noodles & Company

$8.90

-0.35 (-3.78%)

17:06
05/25/18
05/25
17:06
05/25/18
17:06
Syndicate
Breaking Syndicate news story on Noodles & Company »

Noodles & Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPD

Enterprise Products

$27.87

-0.12 (-0.43%)

17:01
05/25/18
05/25
17:01
05/25/18
17:01
Hot Stocks
Enterprise Products conduts open season for West Texas Crude oil expansion »

Enterprise Products…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INO

Inovio

$4.89

0.06 (1.24%)

16:37
05/25/18
05/25
16:37
05/25/18
16:37
Syndicate
Breaking Syndicate news story on Inovio »

Inovio files $250M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCII

Rent-A-Center

$10.14

0.13 (1.30%)

16:36
05/25/18
05/25
16:36
05/25/18
16:36
Hot Stocks
Rent-A-Center 16.8% shareholder Engaged Capital nominates Carol McFate to Board »

On May 25, 2018, Engaged…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKER

Akers Biosciences

$0.59

0.0086 (1.48%)

16:34
05/25/18
05/25
16:34
05/25/18
16:34
Hot Stocks
Akers Biosciences receives delinquency notice from NASDAQ »

Akers Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DHCP

Ditech

$6.60

0.37 (5.94%)

16:31
05/25/18
05/25
16:31
05/25/18
16:31
Hot Stocks
Ditech discloses receipt of late filing notice from NYSE »

Ditech Holding announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPS

Gap

$28.15

-4.82 (-14.62%)

, FL

Foot Locker

$55.97

9.585 (20.67%)

16:30
05/25/18
05/25
16:30
05/25/18
16:30
General news
On The Fly: Top stock stories for Friday »

Stocks on Wall Street…

GPS

Gap

$28.15

-4.82 (-14.62%)

FL

Foot Locker

$55.97

9.585 (20.67%)

HLF

Herbalife Nutrition

$48.76

-5.09 (-9.45%)

IEP

Icahn Enterprises

$69.41

0.22 (0.32%)

FCAU

Fiat Chrysler

$21.82

-0.445 (-2.00%)

DGX

Quest Diagnostics

$105.89

5 (4.96%)

UNH

UnitedHealth

$244.96

2.23 (0.92%)

ROST

Ross Stores

$77.35

-5.6 (-6.75%)

ADSK

Autodesk

$132.80

-5.96 (-4.30%)

AAL

American Airlines

$44.89

1.34 (3.08%)

LUV

Southwest

$52.86

1.65 (3.22%)

DAL

Delta Air Lines

$55.89

1.48 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 30

    May

  • 30

    May

  • 12

    Jun

  • 13

    Jun

  • 14

    Jun

  • 26

    Jun

  • 29

    Jun

16:30
05/25/18
05/25
16:30
05/25/18
16:30
Options
Preliminary option volume of 16.4M today »

Preliminary option volume…

VTL

Vital Therapies

$5.65

-0.475 (-7.76%)

16:26
05/25/18
05/25
16:26
05/25/18
16:26
Syndicate
Breaking Syndicate news story on Vital Therapies »

Vital Therapies files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.